119th Congress · introduced in the House · Apr 10, 2025
Family Cord Blood Banking Act
Official title from Congress.gov
Latest action (Apr 10, 2025): Referred to the House Committee on Ways and Means.
View on Congress.govPolicy area: Taxation
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the House Committee on Ways and Means.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
6 citations.
REVVITY, INC. · lobbying firm or registrant: REVVITY, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 15, 2026 · issue area: Health Issues
$40,000
Spent on own lobbying
Diagnostic test reimbursement and policies Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 H.R. 2810 - Family Cord Blood Banking Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
REVVITY, INC. · lobbying firm or registrant: REVVITY, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 13, 2026 · issue area: Health Issues
$40,000
Spent on own lobbying
Diagnostic test reimbursement and policies Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 H.R. 2810, Family Cord Blood Banking Act S. 4612 SCREEN for Type 1 Diabetes Act Newborn Screening Amendment to NDAA
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
REVVITY, INC. · lobbying firm or registrant: REVVITY, INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 23, 2026 · issue area: Health Issues
$35,000
Spent on own lobbying
Diagnostic test reimbursement and policies Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 H.R. 2810, Family Cord Blood Banking Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
REVVITY, INC. · lobbying firm or registrant: REVVITY, INC.
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 9, 2026 · issue area: Health Issues
$30,000
Spent on own lobbying
…creening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act Medical Device & Pharmaceutical Adjacent Tariffs
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
REVVITY, INC. · lobbying firm or registrant: REVVITY, INC.
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 2, 2025 · issue area: Health Issues
$30,000
Spent on own lobbying
…Testing Proposals related to newborn screening Newborn Screening Saves Lives Act Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act Medical Device & Pharmaceutical Adjacent Tariffs
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
REVVITY, INC. · lobbying firm or registrant: REVVITY, INC.
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Apr 24, 2025 · issue area: Health Issues
$30,000
Spent on own lobbying
…sequencing T-Cell Immune Response Testing Proposals related to newborn screening Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing